Cross-Validated R2 Guided Region Selection for CoMFA Studies

Perspectives in Drug Discovery and Design

Volumn 12, Issue , 1998, Pages 57-69

  Tropsha, Alexander ^a   Cho, Sung Jin ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0542427980     PISSN: 09282866     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1017017601586     Document Type: Article

References (29)

1. Cramer R.D., III, Patterson, D.E. and Bunce, J.D., Comparative molecular field analysis (CoMFA): 1. Effect of shape on binding of steroids to carrier proteins, J. Am. Chem. Soc., 110 (1988) 5959-5967.
2. Cramer, R.D., III, DePriest, S.A., Patterson, D.E. and Hecht., P., The developing practice of comparative molecular field analysis, In Kubinyi, H. (Ed.) 3D QSAR in drug design: Theory, methods and applications, ESCOM, Leiden, The Netherlands, 1993, pp. 443-485.
3. Thibaut, U., Applications of CoMFA and related 3D QSAR approaches, In Kubinyi, H. (Ed.) 3D QSAR in drug design: Theory, methods and applications, ESCOM, Leiden, The Netherlands, 1993, pp. 661-696.
4. Agarwal, A., Pearson, P.P., Taylor, E.W., Li, H.B., Dahlgren, T., Herslof, M., Yang, Y., Lambert, G., Nelson, D.L., Regan, J.W. and Martin, A.R., Three-dimensional quantitative structure-activity relationships of 5-HT receptor binding data for tetrahydropyridinylindole derivatives: A comparison of the Hansch and CoMFA Methods, J. Med. Chem., 36 (1993) 4006-4014.
5. 2-guided region selection for comparative molecular field analysis (CoMFA): A simple method to achieve consistent results, J. Med. Chem., 38 (1995) 1060-1066.
6. Waller, C.L., Oprea, T.I., Giolitti, A. and Marshall, G.R., Three-dimensional QSAR of human immunodeficiency virus (I) protease inhibitors: 1. A CoMFA study employing experimentally-determined alignment rules, J. Med. Chem., 36 (1993) 4152-4160.
7. Debnath, A.K., Hansch, C., Kim, K.H. and Martin, Y.C., Mechanistic interpretation of the genotoxicity of nitrofurans (antibacterial agents) using quantitative structure-activity relationships and comparative molecular field analysis, J. Med. Chem., 36 (1993) 1007-1016.
8. Brusniak, M.Y., Pearlman, R.S., Neve, K.A. and Wilcox, R.E., Comparative molecular field analysis-based prediction of drug affinities at recombinant DIA dopamine receptors, J. Med. Chem., 39 (1996) 850-859.
9. Ortiz, A.R., Pastor, M., Palomer, A., Cruciani, G., Gago, F. and Wade, R.C., Reliability of comparative molecular field analysis models: Effects of data scaling and variable selection using a set of human synovial fluid phospholipase A2 inhibitors, J. Med. Chem., 40 (1997) 1136-1148.
10. Marshall, G.R., Barry, C.D., Bosshard, H.E., Dammkoehler, R.A. and Dunn, D.A., The conformational parameter in drug design: The active analog approach, In Olsen, B.C. and Christoffersen, R.E. (Eds.), Computer-assisted drug design, ACS Symp. Series, Vol. 112, American Chemical Society, Washington, DC, 1979, pp. 205-226.
11. Martin, Y.C., Overview of concepts and methods in computer-assisted rational drug design, Methods Enzymol., 203 (1991) 587-613.
12. Martin, Y.C., Bures, M.G., Danaher, E.A., DeLazzer, J., Lico, I. and Pavlik, P.A., A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists, J. Comput. Aided Mol. Des., 7 (1993) 83-102.
13. Cho, S.J., Serrano, M.G., Bier, J. and Tropsha, A., Structure based alignment and comparative molecular analysis of acetylcholinesterase inhibitors, J. Med. Chem., 39 (1996) 5064-5071.
14. Villalobos, A., Blake, J.F., Biggers, C.K., Butler, T.W., Chapin, D.S., Chen, Y.L., Ives, J.L., Jones, S.B., Liston, D.R. and Nagel, A.A., Novel benzoisoxazole derivatives as potent and selective inhibitors of acetylcholinesterase, J. Med. Chem., 37 (1994) 2721-2734.
15. Ishihara, Y., Hirai, K., Miyamoto, M. and Goto, G., Central cholinergic agents: 6. Synthesis and evaluation of 3-[1-(phenylmethyl)-4-piperidinyl]-1-(2,3,4,5-tetrahydro-1H-1-benzazepin-8-yl)- 1-propanones and their analogs as central selective acetylcholinesterase inhibitors, J. Med. Chem., 37 (1994) 2292-2299.
16. Chen, Y.L., Liston, D., Nielsen, J., Chapin, D., Dunaiskis, A., Hedberg, K., Ives, J., Johnson, J. Jr. and Jones, S., Syntheses and anticholinesterase activity of tetrahydrobenzazepine carbamates, J. Med. Chem., 37 (1994) 1996-2000.
17. Vidaluc, J.L., Calmel, F., Bigg, D., Carilla, E., Stenger, A., Chopin, P. and Briley, M., Novel [2-(4-piperidinyl) ethy](thio)ureas: Synthesis and antiacetylcholinesterase activity, J. Med. Chem., 37 (1994) 689-695.
18. Sasho, S., Obase, H., Ichikawa, S., Kitazawa, T., Nonaka, H., Yoshizaki, R., Ishii, A. and Shuto, K., Synthesis of 2-imidazohdinylidenepropanedinitrile derivatives as stimulators of gastrointestinal motility, J. Med. Chem., 36 (1993) 572-579.
19. Sussman, J.L., Harel, M., Frolow, F., Oefner, C., Goldman, A., Toker, L. and Silman, I., Atomic structure of acetylcholinesterase from Torpedo californica: A prototypic acetylcholine-binding protein, Science, 253 (1991) 8872-8879.
20. Harel, M., Schalk, I., Ehret-Sabatier, L., Bouet, F., Goeldner, M., Hirth, C., Axelsen, P.H., Silman, I. and Sussman, J.L., Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase, Proc. Natl. Acad. Sci. USA, 90 (1993) 9031 -9035.
21. Huang, M.T., Harringtonine, an inhibitor of initiation of protein biosynthesis, Molecular Pharmacol. 11 (1975) 511-519.
22. 1A receptor ligands by the method of comparative molecular field analysis, J. Comp. Chem., 14 (1993) 237-245.
23. The program SYBYL 6.3 is available from Tripos Associates, 1699 South Hanley Road, St Louis, MO 63144, U.S.A.
24. David E. Patterson (Tripos Associates), personal communications.
25. 2-GRS approach, J. Med. Chem., 39 (1996) 1383-1395.
26. Jones, J.P., He, M., Trager, W.F. and Rettie, A.E., Three-dimensional quantitative structure-activity relationship for inhibitors of cytochrome P4502C9, Drug Metabol. Dispos., 24 (1996) 1-6.
27. Baroni, M., Costantino, G., Cruciani, G., Riganelli, D., Valigi, R. and Clementi, S., Generating optimal linear PLS estimations (GOLPE): An advanced chemometric tool for handling 3D-QSAR problems, Quant. Struct.-Act. Relat., 12 (1993) 9-20.
28. Silverman, B.D. and Platt, D.E., Comparative molecular moment analysis (CoMMA): 3D-QSAR without molecular superposition, J. Med. Chem., 39 (1996) 2129-2140.
29. Ginn, C.M.R., Turner, D.B. and Willett, P., Similarity searching in files of three-dimensional chemical structures: Evaluation of the EVA descriptor and combination of rankings using data fusion, J. Chem. Inf. Comput. Sci., 37 (1997) 23-37.